IV Vancomycin-Oral Ciprofloxacin: A Safe and Efficient Therapeutic Protocol for Capd Peritonitis (Preliminary Report)

Millikin S.P. , Matzke G.R. , Keane W.F. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11: 252–60.

Saklayen M.G. CAPD peritonitis. Incidence, pathogens, diagnosis and management. Med Clin North Am 1990; 74: 997–1010.

Williams J.D. , Coles G.A. CAPD peritonitis. Int J Antimicrob Agents 1992; 1: 165–74.

Bailie G.R. , Eisele G. Continuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversy. Ann Pharmacother 1992; 26: 1409–20.

Keane W.F. , Everett E.D. , Golper T.A. Peritoneal dialysis-related peritonitis treatment recommendations. Perit Dial Int 1993; 13: 14–28.

Neville L.O. , Baillod R.A. , Brumfitt W. , Hamilton-Miller J.M.T. Efficacy and safety of teicoplanin in gram-positive peritonitis in patients on peritoneal dialysis. J Antimicrob Chemother 1988; 21: 8123–31.

Freiman J.P. , Graham D.J. , Greene Reed T. , McGoodwin E.B. Chemical peritonitis following the intraperitoneal administration of vancomycin. Perit Dial Int 1992; 12: 57–60.

Obermiller L.E. , Tzamaloukas A.H. , Leymon P. , Avasthi P8 . Intravenous vancomycin as initial treatment for gram-positive peritonitis in patients on chronic peritoneal dialysis. Clin Nephrol 1985; 24: 256–60.

Morse G.D. , Farolino D.F. , Apicella M.A. , Walshe J.J. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1987; 31: 173–7.

Hooper D.C. Quinolones. In: Mandell G.L. , Benett J.E. , Dolin R. , eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995: 364–76.

Madden R.L. , Lipkowitz G.S. , Germain M.J. Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients. Am J Kidney Dis 1995; 25: 611–15.

Waite N.M. , Johnson M.D. , Webster N.R. , Fong I.W. Poor response to oral ciprofloxacin in the treatment of peritonitis in patients on intermittent peritoneal dialysis. Perit Dial Int 1993; 13: 50–4.

Fleming L.W. , Phillips G. , Stewart W.K. , Scott A.C. Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1990; 25: 441–8.

Barretti P. , Bignardi J.H. , Soares V.A. Successful treatment of peritonitis in IPD with oral fluoroquinolone. Perit Dial Int 1993; 13: 192.

Hancock K. , Hulme B. Treatment of CAPD peritonitis with oral ciprofloxacin. Nephrol Dial Transplant 1989; 8: 759.

Nye K.J. , Gibson S.P. , Nwosu A.C. Single dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report. Perit Dial Int 1993; 13: 59–60.

Neu H.C. Synergy offluoroquinolones with other anti microbial agents. Rev Infect Dis 1989; 11: 1–11.

Shalit I. Immunological aspects of new quinolones. Eur J Clin Microbiol Infect Dis 1991; 10: 262–6.